Paper793369
Clinical efficacy of amiodarone as an antiarrhythmic agent.
Rosenbaum MB and 7 others. Am J Cardiol, 1976. Cited by 623 papers, by iCite.
Cite this record
ConductScience Library. Clinical efficacy of amiodarone as an antiarrhythmic agent. Papers, record 793369. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/793369
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amiodarone | Major topic |
| Arrhythmias, Cardiac | Major topic |
| Benzofurans | Major topic |
| Clinical Trials as Topic | |
| Cornea | |
| Drug Evaluation | |
| Heart Conduction System | |
| Humans | |
| Tachycardia | |
| Thyroid Gland | |
| Ventricular Fibrillation |
Source PubMed
Cited by108
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 623 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42658783 | Effect of amiodarone, diltiazem, or both to achieve strict heart rate control in dogs with atrial fibrillation. | J Vet Intern Med | 2026 | https://conductscience.org/library/papers/42658783 | PubMed |
| 41754776 | Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754776 | PubMed |
| 38312206 | Argentina's most important contributions in the field of electrophysiology. | Heart Rhythm O2 | 2024 | https://conductscience.org/library/papers/38312206 | PubMed |
| 37656133 | Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study. | Am J Physiol Heart Circ Physiol | 2023 | https://conductscience.org/library/papers/37656133 | PubMed |
| 36818930 | AMIODARONE AND THYROID DYSFUNCTION. | Acta Clin Croat | 2022 | https://conductscience.org/library/papers/36818930 | PubMed |
| 36296627 | Griseofulvin: An Updated Overview of Old and Current Knowledge. | Molecules | 2022 | https://conductscience.org/library/papers/36296627 | PubMed |
| 33769493 | Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. | Cardiovasc Res | 2021 | https://conductscience.org/library/papers/33769493 | PubMed |
| 30762762 | Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/30762762 | PubMed |
| 30309693 | Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. | Trends Cardiovasc Med | 2019 | https://conductscience.org/library/papers/30309693 | PubMed |
| 28425222 | Class III antiarrhythmic drugs amiodarone and dronedarone impair KIR 2.1 backward trafficking. | J Cell Mol Med | 2017 | https://conductscience.org/library/papers/28425222 | PubMed |
| 27920832 | Risk factors for amiodarone-induced thyroid dysfunction in Japan. | J Arrhythm | 2016 | https://conductscience.org/library/papers/27920832 | PubMed |
| 26705366 | The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. | Cardiovasc Res | 2016 | https://conductscience.org/library/papers/26705366 | PubMed |
| 25053942 | Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. | Int J Endocrinol | 2014 | https://conductscience.org/library/papers/25053942 | PubMed |
| 24999375 | Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation. | Electrofisiol Arritm | 2010 | https://conductscience.org/library/papers/24999375 | PubMed |
| 20730062 | Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. | Vasc Health Risk Manag | 2010 | https://conductscience.org/library/papers/20730062 | PubMed |
| 20717530 | Principal component analysis of HPLC retention data and molecular modeling structural parameters of cardiovascular system drugs in view of their pharmacological activity. | Int J Mol Sci | 2010 | https://conductscience.org/library/papers/20717530 | PubMed |
| 20553056 | Amiodarone: review of pulmonary effects and toxicity. | Drug Saf | 2010 | https://conductscience.org/library/papers/20553056 | PubMed |
| 19952329 | Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria. | Circ Arrhythm Electrophysiol | 2010 | https://conductscience.org/library/papers/19952329 | PubMed |
| 18475534 | Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086. | Mediators Inflamm | 1993 | https://conductscience.org/library/papers/18475534 | PubMed |
| 18234011 | Mauricio Rosenbaum: the internationally renowned electrocardiologist south of the equator (1921-2003). | Ann Noninvasive Electrocardiol | 2008 | https://conductscience.org/library/papers/18234011 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/793369
GET https://conductscience.org/api/papers/v1/793369/cited_by?page=2